Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The Mossman-Pacey Paradox

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Health consequences of androgenic anabolic steroid use

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Response to letter: Observational studies investigating hip fracture risk: a fundamental methodological issue?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  • M Lamberts
  • Olav Wendelboe Nielsen
  • G Y H Lip
  • M H Ruwald
  • Christine Benn Christiansen
  • Søren Lund Kristensen
  • C Torp-Pedersen
  • Morten Lock Hansen
  • G H Gislason
View graph of relations

BACKGROUND: The prognostic significance of age and continuous positive airway pressure (CPAP) therapy on cardiovascular disease in patients with sleep apnoea has not been assessed previously.

METHODS: Using nationwide databases, the entire Danish population was followed from 2000 until 2011. First-time sleep apnoea diagnoses and use of CPAP therapy were determined. Incidence rate ratios (IRRs) of ischaemic stroke and myocardial infarction (MI) were analysed using Poisson regression models.

RESULTS: Amongst 4.5 million individuals included in the study, 33 274 developed sleep apnoea (mean age 53, 79% men) of whom 44% received persistent CPAP therapy. Median time to initiation of CPAP therapy was 88 days (interquartile range 34-346). Patients with sleep apnoea had more comorbidities compared to the general population. Crude rates of MI and ischaemic stroke were increased for sleep apnoea patients (5.4 and 3.6 events per 1000 person-years compared to 4.0 and 3.0 in the general population, respectively). Relative to the general population, risk of MI [IRR 1.71, 95% confidence interval (CI) 1.57-1.86] and ischaemic stroke (IRR 1.50, 95% CI 1.35-1.66) was significantly increased in patients with sleep apnoea, in particular in patients younger than 50 years (IRR 2.12, 95% CI 1.64-2.74 and IRR 2.34, 95% CI 1.77-3.10, respectively). Subsequent CPAP therapy was not associated with altered prognosis.

CONCLUSIONS: Sleep apnoea is associated with increased risk of ischaemic stroke and MI, particularly in patients younger than 50 years of age. CPAP therapy was not associated with a reduced rate of stroke or MI.

Original languageEnglish
JournalJournal of Internal Medicine
Volume276
Issue number6
Pages (from-to)659-66
Number of pages8
ISSN0954-6820
DOIs
Publication statusPublished - Dec 2014

ID: 44824174